LINE SEC Filings - LINEAGE INC 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access LINEAGE SEC filings, including annual 10-K reports, quarterly 10-Q earnings, 8-K material events, and insider trading forms. It details Lineage, Inc.'s operations as a temperature-controlled warehouse REIT and highlights examples of recent filings and their summaries. The platform also offers AI-powered summaries to simplify complex regulatory documents for easier understanding.
Lineage (LINE) officer awarded 32,947 LTIP Units with 2027 vesting
Lineage, Inc. reported that officer Thattai Sudarsan V was granted 32,947 LTIP Units of partnership interest, which will vest fully on April 1, 2027, contingent on continued service. These units, once vested and after specific capital account conditions are met, can be converted into Partnership Common Units. These Common Units may then be redeemed for cash or, at the company's option, one share of common stock per unit, provided at least 18 months have passed since the grant date.
Lineage, Inc. (LINE) CCO receives 20,745 RSU equity grant vesting 2027-2029
Lineage, Inc.'s Chief Commercial Officer, Timothy Conrad Smith, was granted 20,745 time-based restricted stock units (RSUs). These RSUs, which represent contingent rights to common stock, will vest in three equal annual installments on April 1, 2027, 2028, and 2029, provided he continues his service with the company. Following this grant, Smith directly holds 23,234 shares of Lineage, Inc. common stock.
Lineage, Inc. (NYSE: LINE) officer receives 25,626 LTIP Units award
Lineage, Inc. officer Natalie Matsler was granted 25,626 LTIP Units as equity-based compensation, which will vest in three equal annual installments starting April 1, 2027. These units, granted at $0.00 each, can be converted into Partnership Common Units and then redeemed for cash or common stock after certain conditions are met and 18 months have passed. This transaction was reported in an SEC Form 4 filing, detailing the insider's long-term incentive plan.
Lineage (NYSE: LINE) CHRO receives new RSU and LTIP equity grants
Lineage, Inc.'s Chief Human Resources Officer, Burlage Kelly, was granted 1,220 time-based restricted stock units (RSUs) and 1,221 LTIP Units on April 1, 2026. These equity awards vest in three equal annual installments beginning April 1, 2027, subject to continued service. Additionally, 1,516 shares of common stock were withheld to cover tax obligations from previous RSU vesting, and Kelly now directly holds 12,174.16 shares of Lineage common stock.
Equity award gives Lineage (LINE) officer 30,690 new LTIP units
Lineage, Inc. officer Jeffrey Alvarez Rivera received an equity award of 30,690 LTIP units on April 1, 2026. These time-based units, representing interests in Lineage OP, LP, will fully vest on April 1, 2027, contingent on his continued employment. Once vested and certain conditions are met, each LTIP unit can convert into a Partnership Common Unit and subsequently be redeemed for cash or Lineage common stock after 18 months from the grant date.
Lineage (LINE) CAO receives 12,203 RSUs, 276 shares withheld for tax
Lineage, Inc.'s Chief Accounting Officer, Abigail S. Fleming, was granted 12,203 restricted stock units (RSUs) which vest in three equal annual installments starting April 1, 2027. Concurrently, 276 shares were withheld by the company to cover tax obligations from previously vested RSUs, with a reference price of $32.76 per share. Following these transactions, Fleming directly holds 18,482.14 shares of Lineage common stock.
Press Release: Lineage to Report First-Quarter 2026 Financial Results on May 6, 2026
Lineage announced it will report its first-quarter 2026 financial results on May 6, 2026, after the market closes. The company will also host a conference call and webcast to discuss the results on the same day at 4:30 p.m. ET.
Lineage, Inc. (LINE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Lineage, Inc. (NASDAQ:LINE) regarding potential corporate wrongdoing. The firm is encouraging investors who purchased Lineage securities before July 25, 2025, and still hold them, to contact the firm to learn more and assist with the investigation. This class action aims to recover investor capital and ensure corporate accountability.
Lineage to Report First-Quarter 2026 Financial Results on May 6, 2026
Lineage, Inc. (NASDAQ: LINE) announced it will report its first-quarter 2026 financial results on Wednesday, May 6, 2026, before the market opens. A conference call, including a live webcast, will be held at 8:00 a.m. Eastern Time on the same day to discuss these results. An audio replay and archived webcast will be available on the Lineage Investor Relations website for approximately one year.
LINE Stock Price, Quote & Chart | LINEAGE INC (NASDAQ:LINE)
This article provides a detailed overview of LINEAGE INC (NASDAQ: LINE) stock, including its current price of $32.34 and recent performance. It highlights key statistics, technical and fundamental analysis ratings (both low), recent earnings, and analyst forecasts. The company, which operates in temperature-controlled warehousing as a REIT, has a dividend yield of 6.65% and a market capitalization of $7.34 billion.
Lineage, Inc. $LINE Shares Acquired by JPMorgan Chase & Co.
JPMorgan Chase & Co. significantly increased its stake in Lineage, Inc. ($LINE) by purchasing 124,833 shares in Q3, bringing its total to 139,702 shares valued at approximately $5.40 million. This acquisition occurred despite Lineage missing its Q3 EPS estimates and reporting slightly below-consensus revenue, alongside negative net margin and return on equity. The company recently declared a quarterly dividend of $0.5325 per share, representing an annualized dividend of $2.13 and a 6.5% yield.
Wealth Enhancement Advisory Services LLC Acquires 81,306 Shares of Lineage, Inc. $LINE
Wealth Enhancement Advisory Services LLC significantly increased its stake in Lineage, Inc. by 694.7% in Q4, acquiring 81,306 additional shares to hold a total of 93,010 shares valued at approximately $3.35 million. Despite Lineage missing Q4 earnings expectations, the company raised its quarterly dividend to $0.5325, translating to an annualized dividend of $2.13 and a 6.5% yield. Chairman Kevin Patrick Marchetti also increased his holdings, indicating strong insider confidence, with insiders now owning 71.90% of the company.
Lineage Cell (LCTX) Launches Its Latest Cell Therapy Program
Lineage Cell Therapeutics Inc. (LCTX) announced the launch of COR1, a new preclinical cell therapy program targeting corneal endothelial disease, leveraging its AlloSCOPE platform for scalable off-the-shelf therapies. This initiative is a strategic move to expand its ophthalmology presence and support long-term growth, following a strong fourth-quarter revenue report of $6.6 million. The company aims to apply its advanced manufacturing processes to reduce production costs for this new program.
SG Americas Securities LLC Raises Position in Lineage, Inc. $LINE
SG Americas Securities LLC significantly increased its stake in Lineage, Inc. by 3,910.9% in the fourth quarter of the previous year, now owning 261,871 shares valued at $9.17 million. Despite the company missing its quarterly earnings and revenue expectations, Lineage announced a quarterly dividend of $0.5325 per share, resulting in an annualized yield of approximately 6.7%. Additionally, Chairman Kevin Patrick Marchetti purchased 13,300 shares, increasing his total holdings and highlighting insider confidence in the company, where corporate insiders collectively own 71.90% of the stock.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential claims against Lineage, Inc. (NASDAQ: LINE) concerning corporate wrongdoing by the company and its officers/directors. The firm is encouraging shareholders who purchased Lineage securities prior to July 25, 2025, and still hold them, to contact them to assist with the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning there is no upfront cost to investors.
Lineage, Inc. (NASDAQ:LINE) Raises Dividend to $0.53 Per Share
Lineage, Inc. (NASDAQ:LINE) has increased its quarterly dividend to $0.5325 per share, representing a 0.9% increase and an annualized yield of 6.7%. This dividend will be paid on April 21st to shareholders of record on March 31st, despite the company reporting weaker-than-expected earnings and revenue that sent the stock down. Insider buying was also noted, with Chairman Kevin P. Marchetti purchasing 13,300 shares.
Lineage Inc (LINE) Shares Down 3.63% on Mar 27
Lineage Inc (LINE) shares dropped 3.63% on March 27, reaching an intraday low of $32.18 before closing at $32.43. This places the stock just above its 52-week low and significantly below its 52-week high. Wall Street analysts maintain a "Hold" status for LINE, with an average price target suggesting a potential upside of 28.48%.
Lineage to conduct mass layoffs at Highridge Business Park facility
Lineage Logistics, a cold-storage warehousing company, plans to lay off 208 workers at its East Pottsville facility in the Highridge Business Park due to a loss of customers. The layoffs are scheduled for May 27, with employment terminated by May 29. This is the second mass layoff announcement in the Highridge Business Park this month, following Saks & Company LLC's decision to close its fulfillment center.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Lineage, Inc. (NASDAQ: LINE) and its officers/directors. The firm is encouraging shareholders who purchased Lineage securities before July 25, 2025, and still hold them, to contact them for more information and to assist in the investigation. The firm operates on a contingency fee basis for class actions, meaning investors incur no upfront costs.
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lineage, Inc. (NASDAQ: LINE) due to alleged corporate wrongdoing. The firm encourages stockholders who purchased Lineage securities prior to July 25, 2025, and still hold them, to contact them for more information and to assist with the investigation. The representation is on a contingency fee basis.
Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease
Lineage Cell Therapeutics has launched COR1, a new preclinical cell therapy program for corneal endothelial disease, including Fuchs Endothelial Corneal Dystrophy (FECD) and Bullous Keratopathy. This "off-the-shelf" allogeneic therapy utilizes the company's proprietary AlloSCOPE™ platform to address the global shortage of donor corneas. The program aims to provide a consistent, cost-effective solution for a condition affecting millions and plans to advance into preclinical testing.
LINE SEC Filings - LINEAGE INC 10-K, 10-Q, 8-K Forms
This page provides access to SEC filings for LINEAGE INC (LINE), a temperature-controlled warehouse REIT. It details how investors can find 10-K, 10-Q, and 8-K reports, offering insight into Lineage's financial performance, capital structure, governance, and operational metrics. The platform also includes AI-powered summaries of these lengthy filings, highlighting key information for easier understanding.
[EFFECT] Lineage Cell Therapeutics, Inc. SEC Filing
Lineage Cell Therapeutics, Inc. (LCTX) announced that its S-3 Shelf Registration Statement became effective on March 23, 2026, at 4:30 P.M. The filing indicates a neutral impact and sentiment. The company's CIK is 0000876343 and the file number is 333-294202.
LINE SEC Filings - LINEAGE INC 10-K, 10-Q, 8-K Forms
This page provides access to LINEAGE SEC filings, including 10-K annual reports, 10-Q quarterly earnings, and 8-K material events, for investors and traders. It details the company's financial performance, capital structure, and governance as a temperature-controlled warehouse REIT. The filings also include insider trading activities and AI-powered summaries of key points.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lineage, Inc. (LINE) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Lineage, Inc. (LINE) regarding corporate wrongdoing. The firm encourages investors who purchased Lineage securities prior to July 25, 2025, and continue to hold them, to contact them to learn more and assist with the investigation. The investigation aims to restore investor capital and ensure corporate accountability.
Baldwin Wealth Partners LLC MA Buys New Stake in Lineage, Inc. $LINE
Baldwin Wealth Partners LLC MA has acquired a new stake in Lineage, Inc. (NASDAQ:LINE), purchasing 41,193 shares valued at approximately $1.44 million. This comes as other major institutions like Norges Bank and Darlington Partners have also significantly invested in Lineage. Despite missing earnings expectations and a negative net margin, the company's chairman, Kevin Marchetti, increased his holdings, and Lineage raised its quarterly dividend.
Lineage, Inc. (LINE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Lineage, Inc. (NASDAQ:LINE) for alleged corporate wrongdoing. The firm is encouraging shareholders who purchased Lineage securities before July 25, 2025, and still hold them, to contact them for more information and to assist with the investigation. This investigation aims to restore investor capital and ensure corporate accountability.
Does Lineage's (LINE) Higher Dividend Signal Enduring Income Strength or Limited Reinvestment Ambition?
Lineage Inc. has announced a 1% increase in its quarterly cash dividend to US$0.5325 per share, signaling management's intent to return more cash to shareholders. This move comes amidst modest revenue stability and ongoing unprofitability, raising questions about balancing growth funding, higher interest costs, and an uncovered dividend. The article suggests investors consider this dividend increase in the context of Lineage's long-term strategy for temperature-controlled logistics and its ambitious growth projections, which include a $40.44 fair value with a 7% upside.
Does Lineage's (LINE) Higher Dividend Signal Enduring Income Strength or Limited Reinvestment Ambition?
Lineage, Inc. recently increased its quarterly cash dividend by 1% to US$0.5325 per share, signaling management's intent to return more cash to shareholders. This move, however, creates tension between funding growth, managing higher interest costs, and supporting an uncovered dividend, especially as the company navigates unprofitability and a heavy debt load. While the dividend increase is small, it prompts investors to consider whether it reflects enduring income strength or potentially limited reinvestment ambition given the company's financial context and future growth projections.
Lineage Inc (LINE) Stock Price Down 2.83% on Mar 19
Shares of Lineage Inc (LINE) fell by 2.83% on March 19, trading at $36.77, which is 39.68% below its 52-week high and 13.30% above its 52-week low. Wall Street analysts have an average target price of $41.78 for LINE, suggesting a 13.62% upside, and the consensus recommendation from 20 brokerage firms is "Hold". This report was generated using automated technology and GuruFocus financial data.
Lineage completes expansion of Louisville-Winstead cold storage facility
Lineage Inc. has completed the expansion of its Louisville-Winstead cold storage facility in Kentucky, adding over 84,000 square feet and approximately 10,400 pallet positions of temperature-controlled space. This expansion enhances operational flexibility and supports existing customers' needs while offering capacity for new clients in a strategic hub for the North American food supply chain. The facility provides end-to-end supply chain solutions, transportation services, and integrated services like USDA/FDA inspections, leveraging Louisville's key transportation advantages.
Compass Point initiates Lineage stock with buy on growth outlook
Compass Point has initiated coverage on Lineage Inc (NASDAQ:LINE) with a Buy rating and a price target of $47.00, suggesting a potential 27% total shareholder return including its dividend yield. The firm anticipates near-term volatility for Lineage, expecting a return to cash earnings growth after 2026. While Lineage is seen as the superior company compared to Americold Realty Trust, trading at a higher EBITDA multiple, InvestingPro analysis suggests it might be slightly overvalued despite the positive outlook.
Lineage, Inc. (LINE) chair boosts stake with 13,300-share open-market buy
Lineage, Inc. Co-Executive Chairman Kevin Patrick Marchetti purchased 13,300 shares of common stock at a weighted average price of $37.4962 per share. Following this open-market transaction, Marchetti directly owns 113,690 shares and holds significant indirect stakes through KPM Cold Storage and BG Lineage Holdings, LLC. This insider buying activity is seen as a positive indicator for the company.
Lineage (Nasdaq:LINE) - Stock Analysis
This Simply Wall St analysis provides a detailed overview of Lineage (Nasdaq:LINE), the world's largest temperature-controlled warehouse REIT. The report covers the company's valuation, future growth prospects, past performance, financial health, dividends, and ownership, alongside recent news and competitor comparisons. While currently unprofitable, Lineage offers a 5.58% dividend yield and is trading at a significant discount to its estimated fair value.
Why Lineage Inc. Stock Is Suddenly Heating Up
Lineage Inc. (LINE) stock is experiencing a surge due to several positive developments. Chairman Kevin Patrick Marchetti's purchase of 13,300 shares signals strong insider confidence, complemented by a newly announced dividend increase for Q1 2026. Analysts have also raised price targets, citing improved conditions in the cold-storage market, which is beneficial for the REIT.
Lineage, Inc. (NASDAQ:LINE) Receives Consensus Rating of "Hold" from Brokerages
Lineage, Inc. (NASDAQ:LINE) has received a consensus "Hold" rating from nineteen brokerage firms, with four analysts issuing a "sell" rating, eleven a "hold" rating, and four a "buy" rating. The average 1-year target price for the stock is $43.1765. Recent analyst updates include price target increases from Wells Fargo & Company, Citigroup, and Piper Sandler, while Wall Street Zen downgraded the stock to "sell."
Lineage Inc (LINE) Stock Price Up 3.29% on Mar 16
Shares of Lineage Inc (LINE) increased by 3.29% on March 16, reaching an intraday high of $37.89 before closing at $37.63. This places the stock at 38.32% below its 52-week high and 15.95% above its 52-week low. Wall Street analysts have an average one-year price target of $41.18 for LINE, suggesting a potential upside of 9.42%, and the consensus brokerage recommendation is "Hold."
Lineage (NASDAQ:LINE) Chairman Buys $498,750.00 in Stock
Lineage (NASDAQ:LINE) Chairman Kevin Patrick Marchetti recently purchased 13,300 shares of the company's stock for $498,750 on March 12th, increasing his total holdings to 113,690 shares. This acquisition follows another purchase of 11,222 shares on March 9th. The company also announced an increase in its quarterly dividend to $0.5325 per share, resulting in a 5.7% yield, despite reporting weaker-than-expected earnings and revenue in its last quarter.
Lineage Inc director Marchetti buys $498k in shares
Lineage Inc.'s Co-Executive Chairman, Kevin Patrick Marchetti, recently purchased 13,300 shares of common stock for approximately $498,699. This transaction increases his direct holdings to 113,690 shares, alongside significant indirect ownership. The purchase follows the company's Q4 2025 earnings report, which showed steady revenue, and Scotiabank's upgraded price target for Lineage Inc. stock.
Boothbay Fund Management LLC Purchases 61,499 Shares of Lineage, Inc. $LINE
Boothbay Fund Management LLC increased its stake in Lineage, Inc. by 41.8% in the third quarter, purchasing an additional 61,499 shares. Other institutional investors also adjusted their holdings, while insider Kevin Patrick Marchetti bought 11,222 shares. Lineage recently announced a quarterly dividend and released earnings that missed analyst expectations, with several analysts maintaining "Hold" or "Neutral" ratings on the stock.
LCTX SEC Filings - Lineage Cell The 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors and traders to access Lineage Cell Therapeutics (LCTX) SEC filings, including annual 10-K reports, quarterly 10-Q earnings, and 8-K material event forms. It details the company's cell therapy programs and manufacturing approaches, along with recent regulatory disclosures and AI-powered summaries of key financial events and clinical progress. The page also includes current stock data and recent insider trading activities.
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lineage, Inc. (NASDAQ:LINE) securities who bought prior to July 25, 2025, and still hold them. The investigation focuses on whether Lineage and its officers engaged in corporate wrongdoing. The law firm is seeking investors to assist in the investigation, offering representation on a contingency fee basis.
Short Interest in Lineage, Inc. (NASDAQ:LINE) Drops By 27.6%
Lineage, Inc. (NASDAQ:LINE) experienced a significant 27.6% drop in short interest in February, totaling 6,954,589 shares, which represents 10.9% of its shares short and a 4.3-day-to-cover ratio. Despite this, the company missed quarterly earnings expectations, reporting EPS of $0.03 against an expected $0.73 and revenue of $1.34 billion against $1.38 billion. Chairman Kevin Patrick Marchetti increased his stake by 12.59% through a purchase of 11,222 shares, bringing his total to 100,390 shares.
Lineage, Inc. Declares Increased Dividend for First-Quarter 2026
Lineage, Inc. (NASDAQ: LINE) has announced an increased cash dividend of $0.5325 per share for the first quarter of 2026, marking a 1% increase over the previous quarter's annualized rate. The dividend will be paid on April 21, 2026, to shareholders of record as of March 31, 2026. The company is the world’s largest global temperature-controlled warehouse REIT, operating over 500 facilities across North America, Europe, and Asia-Pacific.
Lineage Inc (LINE) Stock Price Down 4.46% on Mar 12
Shares of Lineage Inc (LINE) fell 4.46% on March 12, reaching an intraday low of $37.45. This puts the stock 38.62% below its 52-week high and 15.39% above its 52-week low. Wall Street analysts have an average one-year price target of $41.18, implying a 9.95% upside, and the average brokerage recommendation is a "Hold."
Capital Research Global Investors Buys 120,616 Shares of Lineage, Inc. $LINE
Capital Research Global Investors increased its stake in Lineage, Inc. by 4% in Q3, purchasing an additional 120,616 shares to own 3,152,949 shares valued at $121.8 million. Insider buying by Chairman Kevin P. Marchetti, who increased his holdings by 12.6%, signals confidence despite the company missing quarterly EPS estimates and having negative margins. Lineage currently pays a quarterly dividend yielding approximately 5.4%.
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Investors to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lineage, Inc. (NASDAQ:LINE) securities who bought shares prior to July 25, 2025, and still hold them. The investigation concerns whether the company and its officers engaged in corporate wrongdoing. Investors are encouraged to visit the firm's website or contact them for more information and to assist with the investigation, with no cost to the investors.
Lineage, Inc. $LINE Shares Acquired by Barclays PLC
Barclays PLC significantly increased its stake in Lineage, Inc. ($LINE) by 8,719.8% in Q3, now owning over 1 million shares. Norges Bank also established a large new position. Despite this institutional interest, analysts are mixed with a "Reduce" consensus rating and a $43.00 price target, following Lineage's recent earnings and revenue miss.
Lineage Cell Therapeutics (LCTX) files $100M shelf to issue shares, debt, warrants
Lineage Cell Therapeutics (LCTX) has filed a shelf registration statement (S-3) to offer up to $100 million in various securities, including common shares, preferred shares, debt securities, and warrants. This registration provides the company with flexibility to raise capital for working capital, research and development, and general corporate purposes. Each offering under this shelf will be detailed in a specific prospectus supplement, outlining terms such as amounts, prices, and distribution methods.
